{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:55:28Z","timestamp":1768449328593,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00277-018-3250-8","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T17:59:46Z","timestamp":1517248786000},"page":"885-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mesenchymal stem cells transplantation in hematological patients with acute graft-versus-host disease: characteristics and risk factors for infectious complications"],"prefix":"10.1007","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0483-7329","authenticated-orcid":false,"given":"Igor","family":"Stoma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Karpov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Krivenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Iskrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Milanovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alla","family":"Koritko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly","family":"Uss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"3250_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-014-0098-9","volume":"8","author":"F Baron","year":"2015","unstructured":"Baron F et al (2015) Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society. J Hematol Oncol 8:4","journal-title":"J Hematol Oncol"},{"key":"3250_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-015-0207-4","volume":"8","author":"F Baron","year":"2015","unstructured":"Baron F et al (2015) Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation. J Hematol Oncol 8:107","journal-title":"J Hematol Oncol"},{"issue":"9674","key":"3250_CR3","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","volume":"373","author":"JLM Ferrara","year":"2009","unstructured":"Ferrara JLM, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet (London, England) 373(9674):1550\u20131561. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(09)60237-3","journal-title":"Lancet (London, England)"},{"issue":"5","key":"3250_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.exphem.2005.01.012","volume":"33","author":"G K\u00f6gler","year":"2005","unstructured":"K\u00f6gler G et al (2005) Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp Hematol 33(5):573\u2013583","journal-title":"Exp Hematol"},{"issue":"3","key":"3250_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/sj.leu.2405090","volume":"22","author":"H Ning","year":"2008","unstructured":"Ning H et al (2008) The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia 22(3):593\u2013599","journal-title":"Leukemia"},{"issue":"3","key":"3250_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1600-0609.2012.01824.x","volume":"89","author":"U Forsl\u00f6w","year":"2012","unstructured":"Forsl\u00f6w U et al (2012) Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation. Eur J Haematol 89(3):220\u2013227","journal-title":"Eur J Haematol"},{"issue":"1","key":"3250_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bbmt.2014.09.030","volume":"21","author":"K Zhao","year":"2015","unstructured":"Zhao K et al (2015) Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 21(1):97\u2013104","journal-title":"Biol Blood Marrow Transplant"},{"key":"3250_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1756-8722-7-14","volume":"7","author":"Z Sun","year":"2014","unstructured":"Sun Z, Wang S, Zhao RC (2014) The roles of mesenchymal stem cells in tumor inflammatory microenvironment. J Hematol Oncol 7:14","journal-title":"J Hematol Oncol"},{"issue":"6","key":"3250_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s12185-012-1218-3","volume":"96","author":"M Remberger","year":"2012","unstructured":"Remberger M, Ringd\u00e9n O (2012) Treatment of severe acute graft-versus-host disease with mesenchymal stromal cells: a comparison with non-MSC treated patients. Int J Hematol 96(6):822\u2013824","journal-title":"Int J Hematol"},{"key":"3250_CR10","doi-asserted-by":"publisher","first-page":"690236","DOI":"10.1155\/2012\/690236","volume":"2012","author":"G Lucchini","year":"2012","unstructured":"Lucchini G et al (2012) Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation. Stem Cells Int 2012:690236","journal-title":"Stem Cells Int"},{"issue":"6","key":"3250_CR11","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D et al (1995) 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15(6):825\u2013828","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"3250_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/bmt.2008.316","volume":"43","author":"M Bonin von","year":"2009","unstructured":"von Bonin M et al (2009) Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 43(3):245\u2013251","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"3250_CR13","doi-asserted-by":"publisher","first-page":"E56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):E56\u2013E93","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3250_CR14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1086\/339329","volume":"34","author":"P Ljungman","year":"2002","unstructured":"Ljungman P, Griffiths P, Paya C (2002) Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34(8):1094\u20131097","journal-title":"Clin Infect Dis"},{"issue":"10","key":"3250_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/bmt.2008.386","volume":"43","author":"J Styczynski","year":"2009","unstructured":"Styczynski J et al (2009) Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transplantation 43(10):757\u2013770","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"3250_CR16","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF et al (2016) Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63(4):E1\u2013e60","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3250_CR17","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG et al (2016) Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62(4):E1\u201350","journal-title":"Clin Infect Dis"},{"issue":"12","key":"3250_CR18","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","volume":"98","author":"D Averbuch","year":"2013","unstructured":"Averbuch D et al (2013) European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 98(12):1826\u20131835","journal-title":"Haematologica"},{"issue":"2","key":"3250_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5045\/br.2016.51.2.102","volume":"51","author":"I Stoma","year":"2016","unstructured":"Stoma I et al (2016) Risk factors for mortality in patients with bloodstream infections during the pre-engraftment period after hematopoietic stem cell transplantation. Blood Res 51(2):102\u2013106","journal-title":"Blood Res"},{"issue":"9419","key":"3250_CR20","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K Blanc Le","year":"2004","unstructured":"Le Blanc K, Rasmusson I, Sundberg B, G\u00f6therstr\u00f6m C, Hassan M, Uzunel M, Ringd\u00e9n O (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet (London, England) 363(9419):1439\u20131441. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(04)16104-7","journal-title":"Lancet (London, England)"},{"issue":"3","key":"3250_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1182\/blood-2007-10-119370","volume":"112","author":"H Karlsson","year":"2008","unstructured":"Karlsson H et al (2008) Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses. Blood 112(3):532\u2013541","journal-title":"Blood"},{"issue":"4","key":"3250_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.bbmt.2011.07.023","volume":"18","author":"L Bahr von","year":"2012","unstructured":"von Bahr L et al (2012) Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. Biol Blood Marrow Transplant 18(4):557\u2013564","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"3250_CR23","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/stem.651","volume":"29","author":"MA Cassatella","year":"2011","unstructured":"Cassatella MA et al (2011) Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils. Stem Cells (Dayton, Ohio) 29(6):1001\u20131011","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"8","key":"3250_CR24","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1182\/blood-2011-10-384354","volume":"119","author":"JJ Auletta","year":"2012","unstructured":"Auletta JJ, Deans RJ, Bartholomew AM (2012) Emerging roles for multipotent, bone marrow-derived stromal cells in host defense. Blood 119(8):1801\u20131809","journal-title":"Blood"},{"issue":"4","key":"3250_CR25","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/leu.2010.310","volume":"25","author":"R Meisel","year":"2011","unstructured":"Meisel R et al (2011) Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 25(4):648\u2013654","journal-title":"Leukemia"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3250-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3250-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3250-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T20:31:28Z","timestamp":1548707488000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3250-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,29]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["3250"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3250-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,29]]},"assertion":[{"value":"23 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}